• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about 5/MeO/DMT

Recent news which mentions 5/MeO/DMT

Mike Tyson On Psychedelics: 'The Toad Showed Me God, And It Changed My Life'
November 14, 2024
Tickers NEWS
Tags Rosie Perez 5/MeO/DMT Psychedelic Assisted Therapies
From Benzinga
Imperial College Scientists Dose First Patient With 5-MeO-DMT To Examine One Of The Most Potent Psychedelics' Effects On The Brain
June 03, 2024
Tickers NEWS
Tags psychedelics brain Cannabis Benzinga
From Benzinga
First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression
April 26, 2024
Tickers NEWS
Tags Rob Conley News Psychedelics
From Benzinga
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
March 28, 2024
Tickers ATAI NEWS
Tags Benzinga News Psychedelics
From Benzinga
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
February 29, 2024
Tickers GHRS NEWS
Tags Biotech Cannabis Benzinga
From Benzinga
Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development
January 04, 2024
Tickers ATAI GHRS NEWS
Tags GHRS Benzinga Markets
From Benzinga
GH Research: Steady Expenses And $229M Cash Position For 2026 Runway
November 14, 2023
Tickers GHRS
Tags Markets Cannabis financial results
From Benzinga
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
October 02, 2023
Tickers GHRS
Tags Psychedelics News Psychedelic/Assisted Therapies
From Benzinga
GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026
August 24, 2023
Tickers GHRS
Tags Cannabis Markets Small Cap
From Benzinga
Harnessing The Power Of 5-MeO-DMT For Women Trauma Survivors: A Specialized Retreat
July 03, 2023
Tags Markets Management 5/MeO/DMT
From Benzinga
All On Board For 5-MeO-DMT: This Retreat Hosts Expertly Guided Experiences For Women, BIPOC
July 02, 2023
Tags Market News Guidance Offerings
From Benzinga
GH Research: Q1 2023 Financials And Businesses For European 5-MeO-DMT Depression Treatment Developer
May 11, 2023
Tickers GHRS
Tags 5/MeO/DMT Market News Guidance
From Benzinga
Beckley Psytech Begins Phase IIa Study Of Psychedelic Compound To Treat Depression
May 04, 2023
Tags 5/MeO/DMT Beckley Psytech Ltd Market News
From Benzinga
UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage
April 05, 2023
Tags Market News Cannabis alcohol use disorder
From Benzinga
2 Psychedelics Companies Tout Advanced Clinical Trials, Progress With Key Products
January 11, 2023
Tickers GHRS PHRRF
Tags Benzinga GHRS Small Cap
From Benzinga
New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer's
December 29, 2022
Tickers BMNDF
Tags Psychedelics News Penny Stocks
From Benzinga
Phase 2 Trial For This Psychedelic, Potential Treatment For Severe Depression
December 22, 2022
Tags Beckley Psytech News Psychedelics
From Benzinga
Psychedelic Experiences: UCL Leads First-Ever Brain Imaging Study In Retreat Participants
December 07, 2022
Tags University College London Benzinga Cannabis
From Benzinga
Beyond Magic Mushrooms: Positive Clinical Trial For Treatment-Resistant Depression & Alcoholism
November 16, 2022
Tags Benzinga Clinical Data News
From Benzinga
Psychedelics Company's $60M Series A For Startup To Develop Treatment For Mental Health Disorders
November 02, 2022
Tags Lusaris Therapeutics Market News Catalent
From Benzinga
Can Psychedelics Alleviate Prolonged Grief? Austin's Dell Med School Launches Clinical Trial To Find Out
October 18, 2022
Tags Cannabis Prolonged Grief Markets
From Benzinga
Canadian Psychedelics Firm And Queens College Develop New Transdermal Drug Delivery System
September 27, 2022
Tickers BMNDF
Tags Benzinga BMNDF Mescaline
From Benzinga
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
September 23, 2022
Tickers BMNDF
Tags Markets Cannabis Benzinga
From Benzinga
DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results
August 29, 2022
Tickers DMT PSYBF TRUFF
Tags 5/MeO/DMT Management TRUFF
From Benzinga
GH Research Shares Q2 2022 Financial Results & Business Updates
August 23, 2022
Tickers GHRS
Tags Market News Treatment Resistant Depression 5/MeO/DMT
From Benzinga
Inside A 5-MeO-DMT Retreat: Who Should And Shouldn't Embark On This 'Hero's Journey'
February 12, 2022
Tickers DMT
Tags contributors Market News psychedelics
From Benzinga
5 Psychedelics For Mental Health
February 01, 2022
Tags Benzinga Psilocybin Ayahuasca
From Benzinga
Beckley Psytech Begins Training Therapists For Phase 2 Trial With Toad Venom, 5-MeO-DMT
January 24, 2022
Tags Markets 5/MeO/DMT General
From Benzinga
A Deeper Look At DMT, The 'Spirit Molecule'
January 12, 2022
Tickers DMT
Tags Cannabis psychedelics DMT
From Benzinga
GH Research Announces Positive Trial Results For Treatment-Resistant Depression
December 06, 2021
Tickers GHRS
Tags General Markets Biotech
From Benzinga
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap